Antisense Oligonucleotides Restrict Protein Production, Required for Cell Growth

Antisense oligonucleotides

Antisense oligonucleotides are single-stranded RNA or DNA molecules that are short in length. Antisense oligonucleotides do not affect the activity of already formed proteins, but they do act at the level of messenger RNA in the cell before proteins are produced. Antisense oligonucleotides are used in oncology, central nervous system therapeutics, inflammation therapeutics, diabetes, asthma, hair loss, and other conditions. In genomics, antisense oligonucleotides are also used. Antisense nucleotides include fomivirsen, which is used to treat cytomegalovirus retinitis, and mipomersen, which is used to treat high cholesterol.

The increasing number of launches of novel antisense oligonucleotides products by key market players is one of the major factors driving growth in the global **Antisense Oligonucleotides Market**. For example, Exiqon A/S, which was acquired by Qiagen in 2015, introduced new LNA Antisense Oligonucleotide GapmeRs. In functional analysis, LNA Antisense Oligonucleotide GapmeRs is used to inactivate RNA. Antisense LNA can be used in place of existing siRNAs. LNA Antisense Oligonucleotide is created by combining an advanced bioinformatics algorithm with LNA (locked nucleic acid).

Read more @ https://www.tradove.com/blog/Antisense-Oligonucleotides-Are-Used-In-Order-To-Restrict-the-Protein-Production-Needed-For-Cell-Growth.html